Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2007
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265330 Substituted gamma lactams as therapeutic agents
11/15/2007US20070265325 Nitro Indazole Derivatives
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265310 Biphenyl compounds useful as muscarinic receptor antagonists
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265250 Imidazole compounds
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007DE202004021381U1 Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen Salt of a sulfonic acid with clopidogrel and its use for the preparation of pharmaceutical formulations
11/15/2007CA2651556A1 3-tetrazolylindazoles and 3-tetrazolylpyrazolopyridines and their use
11/15/2007CA2651303A1 Factor xa inhibitors
11/14/2007EP1854793A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY
11/14/2007EP1854791A1 Novel thiophene compound and process for producing caffenofuran or analogue thereof from the same
11/14/2007EP1854787A1 Novel cyclic compound having quinolylalkylthio group
11/14/2007EP1854784A1 Activator for peroxisome proliferator activating receptor
11/14/2007EP1853594A2 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP1853589A1 Process for preparing 2,3-disubstituted indoles
11/14/2007EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007EP1853579A2 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists
11/14/2007EP1853566A1 Cinnoline compounds and their use as liver x receptor modulators
11/14/2007EP1578745B1 BENZOFURAN DERIVATivES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THEREOF
11/14/2007EP1565442B1 Pyridine derivatives as cb2 receptor modulators
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1327629B1 New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses
11/14/2007CN101072774A Enantiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors
11/14/2007CN101072772A 凝血酶受体拮抗剂 Thrombin receptor antagonists
11/14/2007CN101072755A Pyridyl inhibitors of hedgehog signalling
11/14/2007CN101072561A Diaminoalkane aspartic protease inhibitors
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101070304A Quinoline derivatives and their use as mycrobacterial inhibitors
11/14/2007CN100348592C 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/13/2007US7294716 Ring closing 1-arylsulfonylamino-2-amino-benzene with with thiocarbonyldiimidazole to provide a 2-thiobenzimidazole derivative, reacting the intermediate with 2-chloromethyl-pyridine derivative to form N-1-sulfonyl-(2-pyridyl))methylthio]-benzimidazole derivative, oxidizing to form pure arylsulfonyls
11/13/2007US7294645 E.g., N-[[5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methyl]butane-1-sulfonamide and 3-chloro-N-[[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methyl]benzenesulfonamide; cannabinoid receptor antagonists
11/13/2007US7294644 CB 1 receptor inverse agonists
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294635 Substituted isoquinolinones
11/13/2007CA2473202C Pharmaceutical composition for regeneration of cirrhotic liver
11/13/2007CA2342804C Vending machine
11/13/2007CA2248304C Surface modified carbonate materials
11/08/2007WO2007127731A1 4-squarylpiperazine derivatives as antiviral agents
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125913A1 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
11/08/2007WO2007125749A1 Pyrazinecarboxamide derivative and plant disease-controlling agent comprising the same
11/08/2007WO2007125061A1 Spirocompounds useful as modulators for dopamine d3 receptors
11/08/2007WO2007124546A1 Integrase inhibitors 3
11/08/2007WO2007124545A1 Integrase inhibitors - 2
11/08/2007WO2007124544A1 Integrase inhibitors - 1
11/08/2007WO2007104783A3 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators
11/08/2007WO2007092095A3 [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases.
11/08/2007WO2007084450A3 Cannibinoid receptor modulators
11/08/2007WO2007084435A3 Methods for treating hepatitis c
11/08/2007US20070259948 Compounds with antifungal properties and process thereof
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259942 Indolone derivatives like N2-[2-(5-Methyl-1H-3-indolyl)ethyl]-N4-(4-methylphenyl)-6-(1-piperidinyl)-2,4-pyrimidinediamine; galanin-type receptors; antidepressants; anxiolytic agents
11/08/2007US20070259925 Dpp iv inhibitors
11/08/2007US20070259924 such as 5-Chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide, used to prevent or treat conditions characterized by undesired thrombosis and inhibiting the coagulation of blood samples
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259877 Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders
11/08/2007US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/08/2007DE60021370C5 Piperazinderivate verwendbar als ccr5 antagonisten Piperazine derivatives useful as antagonists ccr5
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2649995A1 Amino-ethyl-amino-aryl (aeaa) compounds and their use
11/08/2007CA2648898A1 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
11/08/2007CA2647338A1 Integrase inhibitors-3
11/07/2007EP1852922A2 Mono-, oligo- and poly-bis(thienyl)arylenes and their use as charge transport materials
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
11/07/2007EP1851202A1 Pyridyl acetic acid compounds
11/07/2007EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007EP1850846A1 Composition comprising a jnk inhibitor and cyclosporin
11/07/2007EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists
11/07/2007EP1539712B1 Pyrimidine derivatives and their use as cb2 modulators
11/07/2007CN101068809A Substituted indole compounds and their use as 5-ht6 receptor modulators
11/07/2007CN101068804A Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
11/07/2007CN101068803A Biaryloxymethylarene carboxylic acid compounds
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066945A Process of synthesizing 3-substituted lactan compound
11/07/2007CN100347160C Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/07/2007CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/06/2007US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
11/06/2007US7291632 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
11/06/2007US7291631 aminoalkylpyridines, e.g., N-(1H-benzimidazol-2-ylmethyl)-N-(3-methylpyridin-2-ylmethyl)-butane-1,4-diamine; treating HIV infection and inflammatory conditions such as rheumatoid arthritis; elevating progenitor and stem cell counts, as well as white blood cell counts
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291619 Melanocortin receptor agonists
11/06/2007US7291580 6-(1,1-difluoroalkyl)-4-aminopicolinates and their use as herbicides
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007124329A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124319A1 Inhibitors of c-fms kinase
11/01/2007WO2007123516A1 C-fms kinase inhibitors
11/01/2007WO2007123465A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder
11/01/2007WO2007122634A2 Pyrimidinediones as tyrosine kinase inhibitors
11/01/2007WO2007122482A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
11/01/2007WO2007122173A1 Substituted pyrazinone derivatives for use as a medicine
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 523